Apple Hospitality REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated April 26, 2024, reports on Item 8.01 (Other Events) regarding the Company's upcoming 2024 Annual Meeting of Shareholders. The filing details the proposal to approve the 2024 Omnibus Incentive Plan (the "2024 Plan"), which is intended to supersede and replace the existing 2014 Omnibus Incentive Plan.
Key Financial Metrics and Equity Data
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on equity award data as of the March 26, 2024 record date:
- Total Common Shares Outstanding: 242,346,188
- Shares Available under 2014 Plan: 5,145,772
- Shares Subject to Outstanding Awards (2014 Plan): 1,057,961 (includes 404,476 restricted shares and 653,485 estimated performance shares)
- Stock Options (Directors' Plan): 37,382 unexercised options with a weighted average exercise price of $20.50 and a remaining term of 0.2 years.
- Proposed Shares for 2024 Plan: 7,250,000
Material Changes and Plan Details
The primary material event is the potential transition from the 2014 Plan to the 2024 Plan. If approved, the 2024 Plan will authorize the issuance of 7,250,000 new common shares. The Company has ceased granting awards under the 2014 Plan pending shareholder approval; additional grants under the 2014 Plan will only occur if the 2024 Plan is rejected. The Directors' Plan was terminated in 2015, with no further grants permitted.
Outlook, Risks, and Management Commentary
Management is providing this disclosure to offer shareholders clarity on potential dilution resulting from the 2014 and proposed 2024 Plans. The filing notes that the 2024 Plan is contingent upon shareholder approval at the Annual Meeting. No specific financial risks, contingencies, or unusual items regarding operations are disclosed in this specific report.
Key Facts for Investor Verification
- Verify the outcome of the shareholder vote on the 2024 Omnibus Incentive Plan at the Annual Meeting.
- Confirm the final number of shares authorized under the 2024 Plan if approved (7,250,000).
- Monitor the dilution impact of the 1,057,961 outstanding awards under the 2014 Plan, particularly the 653,485 performance-based shares which are estimated and not yet earned.
- Note that the Directors' Plan has a negligible remaining term (0.2 years) and minimal outstanding options (37,382).